Baxter expects $70M revenue loss from Hurricane Maria

Baxter on Wednesday forecasted manufacturing disruptions caused by Hurricane Maria will cost the company about $70 million in the fourth quarter of fiscal year 2017.

Baxter has three manufacturing facilities in Puerto Rico, all of which are operating on limited manufacturing capacity. As a result, many U.S. hospitals are experiencing shortages of Baxter's IV products.

Baxter CEO José Almeida told analysts the company should achieve normal inventory levels for affected products — and see little financial impact from the supply chain disruptions — by the first quarter of 2018, according to Reuters.

More articles on supply chain:

FDA OKs expanded use for Alexion's ultra-rare disease drug
Survey: 61% of patient advocacy groups have favorable view of devicemakers
Hospitals grapple with medical supply shortages in wake of Hurricane Maria: 4 things to know

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars